ATG12 and head and neck squamous cell carcinoma: A summary of the associated hazard ratios and 95% confidence interval of tumor recurrence (HNSCC Figure 2A and B) and death (Figure 2D and Figure 3A-F) in cancer patients with low ATG12 expressing tumors is plotted in Figure 3G.